Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Non Operating Income (2021 - 2025)

Historic Non Operating Income for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$277366.0.

  • HeartSciences' Non Operating Income fell 18335.9% to -$277366.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$796992.0, marking a year-over-year decrease of 40216.87%. This contributed to the annual value of -$412658.0 for FY2025, which is 3781.08% down from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Non Operating Income is -$277366.0, which was down 18335.9% from -$180875.0 recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Non Operating Income ranged from a high of $172595.0 in Q3 2021 and a low of -$277366.0 during Q4 2025
  • Moreover, its 5-year median value for Non Operating Income was -$87899.5 (2021), whereas its average is -$85029.1.
  • As far as peak fluctuations go, HeartSciences' Non Operating Income soared by 19977.45% in 2024, and later plummeted by 85433.73% in 2025.
  • Over the past 5 years, HeartSciences' Non Operating Income (Quarter) stood at -$77914.0 in 2021, then skyrocketed by 59.43% to -$31606.0 in 2022, then tumbled by 464.56% to -$178435.0 in 2023, then skyrocketed by 45.14% to -$97885.0 in 2024, then crashed by 183.36% to -$277366.0 in 2025.
  • Its Non Operating Income stands at -$277366.0 for Q4 2025, versus -$180875.0 for Q3 2025 and -$173931.0 for Q2 2025.